245 results
8-K
EX-3.2
OCUP
Ocuphire Pharma Inc
13 Jun 24
Amendments to Articles of Incorporation or Bylaws
4:06pm
pursuant to a resolution adopted by a majority of the total number of authorized directors (whether or not there exist any vacancies in previously … be adjourned, from time to time, either by the chairperson of the meeting or by vote of the holders of a majority of the voting power of the shares
DEFR14A
OCUP
Ocuphire Pharma Inc
30 May 24
Revised proxy
4:25pm
on a national securities exchange immediately before and after the amendment becomes effective from a majority of the outstanding shares entitled to vote thereon … to a majority of the votes cast for the amendment by stockholders entitled to vote thereon, meaning that the votes cast by the stockholders
424B3
0yeysbhja0fsv
16 Feb 24
Prospectus supplement
4:31pm
8-K
EX-10.1
o79 dq0osdtsfzsg5o49
5 Dec 23
Departure of Directors or Certain Officers
7:15pm
8-K
EX-99.1
w2okdc9c94366fol6
2 Nov 23
Ocuphire Corporate Presentation November 2023
8:44am
8-K
EX-10.1
aog 9e66rq2xcai
1 Nov 23
Ocuphire Pharma Announces Appointment of George Magrath, M.D., M.B.A., M.S., as Chief Executive Officer and Director
4:21pm
424B5
cyn0i4wkmcryep9f8
14 Aug 23
Prospectus supplement for primary offering
8:00am
8-K
EX-10.1
zp9syd1yx86fp
11 Aug 23
Ocuphire Pharma Announces Financial Results for Second Quarter 2023 and Provides Corporate Update
9:27am
8-K
EX-99.1
o2cs5s z0cx
1 Aug 23
Restore Vision & Clarity Ocuphire Corporate Presentation August 2023
11:21am
8-K
45novur myfo9g
8 Jun 23
Submission of Matters to a Vote of Security Holders
5:58pm
8-K
athldyc628n9pzumxzj
2 Jun 23
Amendments to Articles of Incorporation or Bylaws
4:30pm
8-K
EX-3.1
0g1cr7
2 Jun 23
Amendments to Articles of Incorporation or Bylaws
4:30pm